Prospective Trial of Two Hypofractionated Radiotherapy Regimens Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children
- Conditions
- Pediatric Brain Stem Glioma
- Interventions
- Radiation: Hypofractionated Arm (2)Radiation: Hypofractionated Arm (1)Radiation: Conventional Arm (3)
- Registration Number
- NCT01878266
- Lead Sponsor
- Children's Cancer Hospital Egypt 57357
- Brief Summary
This Trial offers a reduction in patient burden, which is especially preferable in children with a poor compliance and poor performance status. This prospective randomized trial was extension to the previous controlled prospective study performed in Children's Cancer Hospital, Egypt and registered at clinicaltrials.com (NCT01635140). The ultimate aim of this work is to demonstrate noninferiority of the hypofractionated regimens relative to the conventional regimen in a controlled randomized clinical study.
- Detailed Description
In this study will add a third arm in which we will increase in the total dose to 4500 cGy in 15 fractions in 3 weeks may lead to improvement in Over-all survival or Progression-Free Survival.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 119
- Newly diagnosed patients with a diffuse intrinsic brainstem glioma
- Aged 2-18years,
- Have symptoms for less than 3 months and at least two findings of the neurologic triad: cranial nerve deficits, ataxia, or long tract signs.
- No performance criteria were required for entry onto the study.
- Children were not eligible if they had received any prior therapy other than steroids Treatment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Hypofractionated Arm (2) Hypofractionated Arm (2) The same planning and treatment procedures will be performed. The total dose will be 4500 cGy in 15 fractions in 3 weeks; giving 300 cGy per fraction. Hypofractionated Arm (1) Hypofractionated Arm (1) A total dose of 39 Gy in daily fractions of 3 Gy, 5 Fractions per week , by conformal radiotherapy sparing of the supratentorial brain. The planning target volume included the tumor as defined by the T2-weighted MRI images with a margin of 1.5-2.0 cm. Margins were adjusted for bony structures and tentorium. With exception of steroids, no neoadjuvant, concomitant, or adjuvant systemic treatment was allowed Conventional Arm (3) Conventional Arm (3) The same planning and treatment procedures will be performed with 54.0 Gy in 30 fractions giving 1.8 Gy per fraction.
- Primary Outcome Measures
Name Time Method Median overall-free survival 3 years
- Secondary Outcome Measures
Name Time Method Progression-free survival 3 years
Trial Locations
- Locations (1)
Children's Cancer Hospital Egypt 57357
🇪🇬Cairo, Egypt